ClinicalTrials.Veeva

Menu

Rational Fluid Therapy in Germany (RaFTinG)

L

Ludwig Maximilian University of Munich

Status

Unknown

Conditions

Patients in ICU

Study type

Observational

Funder types

Other

Identifiers

NCT01122277
337 -09/2009-366-f-S

Details and patient eligibility

About

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

Full description

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany.

Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Enrollment

4,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ICU patients with an indication for fluid/volume therapy

Exclusion criteria

  • Patients hospitalized by order of a court of law or a government agency

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems